Cyclin-dependent kinases regulate the antiproliferative function of Smads

Nature

Volumn 430, Issue 6996, 2004, Pages 226-231

  Matsuura, Isao ^a,b,c   Denissova, Natalia G ^a,b,c   Wang, Guannan ^a,b,c   He, Dongming ^a,b,c   Long, Jianyin ^a,b,c   Liu, Fang ^a,b,c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHYSIOLOGY; PROTEINS; SUBSTRATES; TUMORS;

ANTIPROLIFERATIVE FUNCTIONS; GROWTH INHIBITORY RESPONSES;

CELL CULTURE;

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; GLUTATHIONE TRANSFERASE; MITOGEN ACTIVATED PROTEIN KINASE; SMAD PROTEIN; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TRITIUM;

BIOLOGY;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CONTROLLED STUDY; EMBRYO; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; GENE MUTATION; GENETIC TRANSCRIPTION; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; RETROVIRUS;

ANIMALS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; FIBROBLASTS; G1 PHASE; GENE EXPRESSION REGULATION; GENES, MYC; GENES, REPORTER; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; S PHASE; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 3142546336     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02650     Document Type: Article

References (30)

1. Massagué, J., Blain, S. W. & Lo, R. S. TGF-β signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309 (2000).
2. Derynck, R., Akhurst, R. J. & Balmain, A. TGF-β signaling in tumor suppression and cancer progression. Nature Genet. 29, 117-129 (2001).
3. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
4. Sherr, C. J. & Roberts, J. M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512 (1999).
5. Hall, M. & Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res. 68, 67-108 (1996).
6. Sherr, C. J. Cancer cell cycles. Science 274, 1672-1677 (1996).
7. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature 371, 257-261 (1994).
8. INK4B through an Sp1 consensus site. J. Biol. Chem. 270, 26750-26753 (1995).
9. Moustakas, A. & Kardassis, D. Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interaction between Sp1 and Smad family members. Proc. Natl Acad. Sci. USA 95, 6733-6738 (1998).
10. Waf1/Cip1 regulation by transforming growth factor-β. J. Biol. Chem. 275, 29244-29256 (2000).
11. Ink4B transcription in response to TGF-β. EMBO J. 19, 5178-5193 (2000).
12. Seoane, J., Le, H. V., Shen, L., Anderson, S. A. & Massague, J. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117, 211-223 (2004).
13. Chen, C. R., Kang, Y. & Massagué, J. Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor growth arrest program. Proc. Natl Acad. Sci. USA 98, 992-999 (2001).
14. Yagi, K. et al. c-myc is a downstream target of the Smad pathway. J. Biol. Chem. 277, 854-861 (2002).
15. Chen, C.-R., Kang, Y., Siegel, P. M. & Massagué, J. E2F4/5 and p107 as Smad cofactors linking the TGF-β receptor to c-myc repression. Cell 110, 19-32 (2002).
16. Frederick, J. P., Liberati, N. T. Waddell, D. S., Shi, Y. & Wang, X. F. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell. Biol. 24, 2546-2559 (2004).
17. Zhu, Y., Richardson, J. A., Parada, L. F. & Graff, J. M. Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714 (1998).
18. Han, S. U. et al. Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene 23, 1333-1341 (2004).
19. Ashcroft, G. S. et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nature Cell Biol. 1, 260-266 (1999).
20. Yang, X. et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. 18, 1280-1291 (1999).
21. Datto, M. B. et al. Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol. Cell. Biol. 19, 2495-2504 (1999).
22. INK4B induction and growth inhibition in astrocytes is Smad3-dependent and a pathway prominently altered in human glioma cell lines. J. Biol. Chem. 274, 35053-35058 (1999).
23. Laiho, M., DeCaprio, J. A., Ludlow, J. W., Livingston, D. M. & Massagué, J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175-185 (1990).
24. Kitagawa, M. et al. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2. EMBO J. 15, 7060-7069 (1996).
25. Kretzschmar, M., Doody, J., Timokhina, I. & Massagué, J. A mechanism of repression of TGF-β/Smad signaling by oncogenic ras. Genes Dev. 13, 804-816 (1999).
26. Porter, P. L. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222-225 (1997).
27. Matsuura, I. & Wang, J. Demonstration of cyclin-dependent kinase inhibitory serine/threonine kinase in bovine thymus. J. Biol. Chem. 271, 5443-5450 (1996).
28. Phelps, D. E. & Xiong, Y. Assay for activity of mammalian cyclin D-dependent kinases CDK4 and CDK6. Methods Enzymol. 283, 194-204 (1997).
29. Kim, M. I. et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res. 62, 2999-3004 (2002).
30. Swift, S., Lorens, J., Achacoso, P. & Nolan, G. P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. in Curr. Protocols Immunol. (eds Coligan, J. E. et al.) Unit 10.28, Suppl. 31 (John Wiley & Sons, 1999).